Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival

P Kellish, D Shabashvili, MM Rahman… - The Journal of …, 2019 - Am Soc Clin Investig
Oncolytic virotherapy has been proposed as an ablative and immunostimulatory treatment
strategy for solid tumors that are resistant to immunotherapy alone; however, there is a need …

Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics

J Lv, C Wu, J Li, F Chen, S He, Q He, G Zhou, J Ma… - BMC medicine, 2022 - Springer
Background Significant intertumoral heterogeneity exists as antitumor treatment is
introduced. Heterogeneous therapeutic responses are conventionally evaluated by imaging …

MDT treatment of small cell lung cancer complicated with adenocarcinoma: a case report and literature review

QU Zihan, LIU Jiewei, LUO Feng, LI Lu… - Zhongguo Fei Ai …, 2021 - search.proquest.com
小细胞肺癌 (small cell lung cancer, SCLC) 是肺癌中恶性程度和死亡率最高的类型.
目前的一线标准治疗方式仍是以依托泊苷和铂类为主的化疗方案. 然而, 对于一线治疗后进展的 …

Genomic profiling and clinicopathological characteristics of neuroendocrine tumors of the lung in East Asian patients

M Kim, YS Chung, KA Kim, HS Shim - In vivo, 2020 - iv.iiarjournals.org
Background/Aim: In recent years, the genomic landscape of neuroendocrine tumors (NETs)
of the lung has been investigated. However, more data are necessary to elucidate the …

[HTML][HTML] 小细胞肺癌合并腺癌MDT 治疗报道及文献综述

瞿子涵, 刘洁薇, 罗锋, 李潞, 朱玲玲… - Chinese Journal of Lung …, 2021 - ncbi.nlm.nih.gov
小细胞肺癌( small cell lung cancer, SCLC) 是肺癌中恶性程度和死亡率最高的类型。
目前的一线标准治疗方式仍是以依托泊苷和铂类为主的化疗方案。 然而 …